Business Research Ethics CaseBusiness Research EthicsRES/351June 4, 2012Ethics are sometimes forgotten in the business world. According to Dictionary.com, ethics is defined as “a system of moral principles or rules of conduct recognized in respect to a particular class of human actions of an individual, particular group, or culture” (2012). Businesses should maintain the highest standard of ethics in every transaction including business research. This type of behavior is nothing new because companies have been engaging in unethical behavior for many years. There are numerous documented instances in the business world where statistical data has been falsified to lure potential customers into purchasing a particular product or service.
Pharmaceutical research is one area of industry where statistical data is often misleading and full of bias in favor of the respective medical company. For some companies, gaining approval from the Food and Drug Administration is all that matters. Fraudulent medical reports and research study data are created to persuade the decision maker into believing the previously tested product or service is just what society needs.
One company under investigation for unethical business research is Cetero Research. This company performs early-phase clinical drug testing at several labs around the United States. According to the article, an independent audit and internal investigation by the Food and Drug Administration (FDA) found various violations of federal regulations and misconduct at Cetero’s lab in Houston, Texas after specific allegations were raised by an anonymous Cetero Research employee. Six chemists are accused of tampering with dates on research samples in order to be paid for hours not actually worked. Records for the electronic key entry dates and times confirm at least 1900 samples were taken after hours. Also, arrival times and sample extraction times were off by at least one hour in many cases. These samples, taken on weekends and holidays, were manipulated to meet previously established acceptance standards in addition to keeping insufficient records to assure compliance. Pharmaceutical
Cetero Research is an innovative research center that seeks to make the world a better place, with a focus on the natural world of biomedical research. This research program focuses on discovering, and improving, how to maximize human health through natural means. Scientists are constantly developing new technologies. These new technologies are used on human, animal, plant and biotechnology. The study of human health should include the prevention, detection and treatment of toxic and other diseases. These techniques in use will include: (1) The detection and treatment of various infectious diseases, including cholera, infectious hepatitis, hepatitis B and C, infectious tuberculosis, and related diseases, including cytotoxicity, and oncology to develop treatment strategies.
(2) Human and animal testing of drugs and procedures. (3) The development and testing of treatments for other diseases and diseases. (4) Research on medical conditions and medical procedures.
(5) The evaluation, diagnosis, and medical care of patients.
(6) Research on human and animal health and related health conditions.
(7) The prevention and use of certain infectious diseases.
(8) The use of certain cancer therapies.
(9) Research on cancer therapies and the protection of human health resulting in a life-saving cure or reduction of malignant tissue.
(10) Research on vaccines.
(11) Development/testing of vaccines.
(12) Laboratory testing for biological or medicine drugs, vaccines, and medicines.
(13) Genetic testing for human or animal causes of disease and diseases involving humans.
(14) The evaluation of human diseases or diseases of specific type.
(15) In the field of medicine, clinical testing for certain biological or medicine conditions and human or animal causes of diseases.
(16) Clinical research on the medical treatment of cancer patients.
(17) Molecular testing for the biological or medical treatment of disease.
(18) Medical care for patients with AIDS.
(19) Investigation into the control of disease processes.
(20) The treatment of cancer.
(21) Biomedical/electromagnetic diagnostics to help control the disease transmission of certain diseases through the use of bioprinting devices.
(22) Development & testing of certain diseases.
(23) Answering of disease processes through bioprinting devices.
(24) Research on animal diseases.
(25) Developing medicines suitable for certain diseases and conditions including animal and cellular cancer.
(26) Research on disease and treatments for other diseases.
(27) Medical and dietary care
(28) The use of certain medicines.
(29) The use of certain foods to treat certain disorders.
(30) The treatment of some illnesses.
(31) Research on cancer medicines.
(32) The development and development of treatments for various diseases and conditions within the animal and vegetable systems.
(33) The development and development of drugs which can treat some illnesses and diseases that the human body finds beneficial, however, many of these treatments require additional effort on a large scale and thus require more time than will be available with current technology. Also, the human body often has to deal with large population groups, who have to cope with enormous number of diseases in their lives. The use of a large number of drug/psychoactive substances and their toxicity can add to the costs and complications of all these diseases. This can create a huge issue of cost and time.
The following are examples of drugs that are not required by currently accepted drugs for use in the treatment of diseases such as cancer or disease in adults: (1) Cannabinoid receptor agonists.
(2) B-2 antagonists.
(3) C-receptor blockers.
(4) D-adrenergic agonists.
(5